Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Finland Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20065
20072
20091
20102
20112
20121
20131
20143
20151
20181
20202
20212
20232
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated5
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S5
AstraZeneca4
Sanofi3
Eli Lilly and Company2
Intra-Cellular Therapies, Inc.2
Janssen Research & Development, LLC2
Neumora Therapeutics, Inc.2
Neurocrine Biosciences2
Pfizer2
Shire2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder33
Depressive Disorder2
Anhedonia1
Mental Disorders1
Mood Disorders1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.